{
    "title": "Teva Pharm regains market trust amid restructuring",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7995611/Teva-Pharm-Q4-results-just-ahead-expectations.html",
    "date": "2020-02-12",
    "keywords": [
        "teva",
        "revenue",
        "austedo",
        "schultz",
        "drug",
        "ajovy",
        "settlement",
        "share",
        "quarter",
        "debt",
        "tova",
        "cohen",
        "scheer",
        "restructuring",
        "york",
        "growth",
        "year",
        "cost",
        "end",
        "line",
        "market",
        "tel",
        "aviv",
        "wednesday",
        "drugmaker",
        "corner",
        "fourthquarter",
        "trade",
        "company",
        "treatment",
        "optimism",
        "lawsuit",
        "kare",
        "confidence",
        "sector",
        "fact",
        "performance",
        "case",
        "past",
        "increase",
        "respiratory",
        "sclerosis",
        "copaxone",
        "refinitiv",
        "plan",
        "base",
        "analyst",
        "ami",
        "fadia",
        "guidance",
        "manufacturing",
        "process",
        "workforce",
        "stood",
        "business",
        "america",
        "pricing",
        "launch",
        "autoinjector",
        "framework",
        "attorney",
        "worth",
        "suboxone",
        "cash",
        "state",
        "trial",
        "march",
        "forecast",
        "outlook",
        "use",
        "syndrome",
        "stage",
        "reporting",
        "editing",
        "mark",
        "potter",
        "fentonjane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}